Description: Ceapro Inc. develops and utilizes core technologies to supply materials and compounds to the life sciences and personal care and cosmetics industries. The Company discovers, develops, and produces natural health products derived from oats and other grains. Its products include natural active ingredients, including beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides.
Home Page: www.ceapro.com
7824 – 51 Avenue NW
Edmonton,
AB
T6E 6W2
Canada
Phone:
780 421 4555
Officers
| Name | Title |
|---|---|
| Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc., MBA | CEO, Pres & Director |
| Ms. Stacy Prefontaine CPA, CA | CFO & Corp. Sec. |
| Dr. Bernhard Seifried | Sr. Director of Research & Technology |
| Ms. Sigrun Watson | Chief Revenue Officer |
Exchange: OTCQX
Country: US
Currency: US Dollar ($)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Chemicals |
| GIC Sub-Industry: | Specialty Chemicals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 9.488 |
| Price-to-Book MRQ: | 1.7024 |
| Price-to-Sales TTM: | 1.8858 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |